Zavegepant nasal spray for the acute treatment of migraine: A meta analysis

BACKGROUND: Zavegepant nasal spray is a novel CGRP receptor antagonist that has been developed for the acute treatment of migraine – a prevalent disease leading to disability and economic burden. The meta-analysis aims to quantify the efficacy of Zavegepant compared to standard care or placebo in ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Waqas, Muhammad, Ansari, Faizan Ur Rehman, Nazir, Anam, Hussain, Khadija Saleem Raza, Sarfraz, Zouina, Sarfraz, Azza, Sarfraz, Muzna, KC, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615551/
https://www.ncbi.nlm.nih.gov/pubmed/37904462
http://dx.doi.org/10.1097/MD.0000000000035632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615551/
https://www.ncbi.nlm.nih.gov/pubmed/37904462
http://dx.doi.org/10.1097/MD.0000000000035632

Ejemplares similares